{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:59:55Z","timestamp":1790164795403,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatitis C virus (HCV) infection remains a major public health concern in sub-Saharan Africa (SSA), where epidemiological data are limited, particularly in countries such as Angola. Herein, we estimated the seroprevalence of HCV infection and demographic characteristics related to the infection in a large urban population in Luanda, the capital city of Angola.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective cross-sectional analysis of existing laboratory records from 5,399 individuals using an immunoassay test for detecting anti-HCV antibodies, between 2020 and 2024 at the MEDIAG Laboratory, a private healthcare facility in Luanda, Angola.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 1.1% (57\/5399) of participants were anti-HCV reactive. The mean age of reactive individuals was significantly higher than that of non-reactive participants (47.5\u2009\u00b1\u200915.7 vs. 37.3\u2009\u00b1\u200912.5 years,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Young individuals aged 20\u201330 years (AOR: 0.30,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003) or 31\u201340 years (AOR: 0.31,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) showed lower odds of anti-HCV reactivity. Males showed numerically higher anti-HCV reactivity (AOR: 1.26,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.407), but this association did not reach statistical significance. Between 2020 and 2024, overall anti-HCV reactivity among tested individuals changed slightly, from 0.9% to 1.1%, without statistical evidence of a temporal increase (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.984). Among the 57 anti-HCV-reactive individuals, changes in the distribution of cases across age groups were observed over time, with the proportion in those under 20 years ranging from 0% to 5.9%, in those aged 20\u201330 years from 12.5% to 23.5%, and in those over 40 years from 50% to 64.7%, while a decrease was observed in the 31\u201340 years group (37.5% to 5.9%). Similarly, variations were observed by gender, with females decreasing from 75% to 47.1% and males increasing from 25% to 52.9%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Anti-HCV reactivity was more frequent among individuals aged over 40 years. The observed age and gender distributions may help identify groups for further surveillance and targeted screening strategies. However, these findings are based on individuals tested at a private healthcare facility and on anti-HCV antibody reactivity without HCV RNA confirmation, limiting inference regarding active infection and population prevalence. Further population-based studies with HCV RNA confirmation are needed to better estimate the true burden of HCV infection in Angola.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13928-w","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:34:22Z","timestamp":1782930862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seroprevalence of hepatitis C virus infection among individuals attending a private clinic in Luanda, Angola"],"prefix":"10.1186","volume":"26","author":[{"given":"Jos\u00e9","family":"Fernando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louren\u00e7o","family":"Quixari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Sangombe","family":"Epalanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio Jorge","family":"Pascoal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson K.","family":"Cassinela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Inaculo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmundo","family":"P\u00facuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euclides","family":"Sacomboio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingos","family":"Jandondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana M. K.","family":"Sebasti\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L. S.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngiambudulu","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pingarilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana B.","family":"Abecasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1232-0119","authenticated-orcid":false,"given":"Cruz S.","family":"Sebasti\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"13928_CR1","unstructured":"World Health Organization. National guideline for the diagnosis and management of hepatitis C. 2019."},{"key":"13928_CR2","doi-asserted-by":"publisher","unstructured":"Li Y, Li Z, Chen R, Jia C, Liu H, Tang M, et al. Global, regional and national burden of chronic hepatitis C, 1990-2021: a systematic analysis for the GBD Study 2021. J Viral Hepat. 2025;32. https:\/\/doi.org\/10.1111\/jvh.70053.","DOI":"10.1111\/jvh.70053"},{"key":"13928_CR3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S2468-1253(25)00068-8","volume":"10","author":"L Hiebert-Suwondo","year":"2025","unstructured":"Hiebert-Suwondo L, Manning J, Tohme RA, Buti M, Kondili LA, Spearman CW, et al. A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles. Lancet Gastroenterol Hepatol. 2025;10:685\u2013700. https:\/\/doi.org\/10.1016\/S2468-1253(25)00068-8.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"13928_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/biology12010023","volume":"12","author":"B Songtanin","year":"2022","unstructured":"Songtanin B, Nugent K. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus Infection. Biology (Basel). 2022;12:23. https:\/\/doi.org\/10.3390\/biology12010023.","journal-title":"Biology (Basel)"},{"key":"13928_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.7196\/SAMJ.6097","volume":"103","author":"H Guimar\u00e3es Nebenzahl","year":"2013","unstructured":"Guimar\u00e3es Nebenzahl H, Lopes \u00c2, Castro R, Pereira F. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola. South Afr Med J. 2013;103:186. https:\/\/doi.org\/10.7196\/SAMJ.6097.","journal-title":"South Afr Med J"},{"key":"13928_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/sextrans-2019-054249","volume":"96","author":"D Oliveira","year":"2020","unstructured":"Oliveira D, Martins M, do R, Castro R, Cordeiro L, Barroso MR, Nazar\u00e9 MA, et al. Seropositivity rate and sociodemographic factors associated to HIV, HBV, HCV and syphilis among parturients from Irene Neto Maternity of Lubango city, Angola. Sex Transm Infect. 2020;96:587\u20139. https:\/\/doi.org\/10.1136\/sextrans-2019-054249.","journal-title":"Sex Transm Infect"},{"key":"13928_CR7","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1002\/jmv.26148","volume":"92","author":"CS Sebasti\u00e3o","year":"2020","unstructured":"Sebasti\u00e3o CS, Neto Z, Jandondo D, Mirandela M, Morais J, Brito M. HIV, hepatitis B virus, hepatitis C virus, and syphilis among pregnant women attending antenatal care in Luanda, Angola: Seroprevalence and risk factors. J Med Virol. 2020;92:3265\u201370. https:\/\/doi.org\/10.1002\/jmv.26148.","journal-title":"J Med Virol"},{"key":"13928_CR8","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.3390\/pathogens10121633","volume":"10","author":"LB Peliganga","year":"2021","unstructured":"Peliganga LB, Mello VM, de Sousa PSF, Horta MAP, Soares \u00c1D, Nunes JP da. Transfusion Transmissible Infections in Blood Donors in the Province of Bi\u00e9, Angola, during a 15-Year Follow-Up, Imply the Need for Pathogen Reduction Technologies. Pathogens. 2021;10:1633. https:\/\/doi.org\/10.3390\/pathogens10121633.","journal-title":"Pathogens"},{"key":"13928_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-025-04700-3","author":"CS Sebasti\u00e3o","year":"2025","unstructured":"Sebasti\u00e3o CS, Jandondo D, Vig\u00e1rio J, Ant\u00f3nio F, Sebasti\u00e3o JMK, Silva MLS, et al. Seroprevalence and Risk Factors of STIs among Rejected Blood Donors at the National Blood Transfusion Service in Angola. AIDS Behav. 2025. https:\/\/doi.org\/10.1007\/s10461-025-04700-3.","journal-title":"AIDS Behav"},{"key":"13928_CR10","doi-asserted-by":"publisher","unstructured":"Chen S, Xu Y, Li B, Yu T, Wu X, Jiang Y, et al. Pathway to hepatitis C elimination: insights from a large tertiary hospital in South China. Ann Med. 2025;57. https:\/\/doi.org\/10.1080\/07853890.2025.2464931.","DOI":"10.1080\/07853890.2025.2464931"},{"key":"13928_CR11","doi-asserted-by":"publisher","unstructured":"Yue Z, Xia C, Wang H. Performance evaluation of the Mindray anti-HCV assay for the detection of hepatitis C virus infection. J Clin Lab Anal. 2018;32. https:\/\/doi.org\/10.1002\/jcla.22600.","DOI":"10.1002\/jcla.22600"},{"key":"13928_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1473-3099(15)00006-7","volume":"15","author":"VB Rao","year":"2015","unstructured":"Rao VB, Johari N, du Cros P, Messina J, Ford N, Cooke GS. Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15:819\u201324. https:\/\/doi.org\/10.1016\/S1473-3099(15)00006-7.","journal-title":"Lancet Infect Dis"},{"key":"13928_CR13","doi-asserted-by":"publisher","first-page":"16478","DOI":"10.1038\/s41598-025-01089-w","volume":"15","author":"CS Sebasti\u00e3o","year":"2025","unstructured":"Sebasti\u00e3o CS, Machado MG, Vig\u00e1rio J, Comandante F, Armando A, Silva MLS, et al. Trends in active hepatitis B virus infection and associated risk factors among blood donor candidates from Luanda. Angola Sci Rep. 2025;15:16478. https:\/\/doi.org\/10.1038\/s41598-025-01089-w.","journal-title":"Angola Sci Rep"},{"key":"13928_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ajg.2025.01.013","volume":"26","author":"D Sayed","year":"2025","unstructured":"Sayed D, Bakry R, Mikhail N, Faris M, Rageh F, Samir Abdelhafiz A, et al. The prevalence of infection and potential risk factors for HBV and HCV among healthcare workers not vaccinated against HBV: A study from a cancer center in Egypt, 2021\u20132022. Arab J Gastroenterol. 2025;26:201\u20136. https:\/\/doi.org\/10.1016\/j.ajg.2025.01.013.","journal-title":"Arab J Gastroenterol"},{"key":"13928_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12558-013-0275-8","volume":"5","author":"MC Kew","year":"2013","unstructured":"Kew MC. Hepatitis C virus-induced hepatocellular carcinoma in sub-Saharan Africa. Journal Africain du Cancer \/. Afr J Cancer. 2013;5:169\u201374. https:\/\/doi.org\/10.1007\/s12558-013-0275-8.","journal-title":"Afr J Cancer"},{"key":"13928_CR16","doi-asserted-by":"publisher","first-page":"104894","DOI":"10.1016\/j.drugpo.2025.104894","volume":"143","author":"E Saayman","year":"2025","unstructured":"Saayman E, Hechter VB, Sishwili NS, Sonderup MW. A decentralized point of service triple prevention and treatment model for hepatitis B, C and HIV in people who inject drugs in South Africa. Int J Drug Policy. 2025;143:104894. https:\/\/doi.org\/10.1016\/j.drugpo.2025.104894.","journal-title":"Int J Drug Policy"},{"key":"13928_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12939-025-02582-4","volume":"24","author":"S Mortazhejri","year":"2025","unstructured":"Mortazhejri S, Thomas IM, Patey AM, Alghamyan A, Cooper C, Mansour S, et al. Perceptions about hepatitis C and barriers and enablers to screening and treatment among Egyptian immigrants to Canada: a theory-informed qualitative study. Int J Equity Health. 2025;24:203. https:\/\/doi.org\/10.1186\/s12939-025-02582-4.","journal-title":"Int J Equity Health"},{"key":"13928_CR18","doi-asserted-by":"publisher","unstructured":"Saaed FMA, Ongerth JE. Prevalence of hepatitis B and hepatitis C in migrants from sub-Saharan Africa at Al Kufra in SE Libya in transit toward Europe. 2022. https:\/\/doi.org\/10.1101\/2022.02.11.22270214.","DOI":"10.1101\/2022.02.11.22270214"},{"issue":"suppl1","key":"13928_CR19","doi-asserted-by":"publisher","first-page":"S650","DOI":"10.1093\/ofid\/ofy210.1856","volume":"5","author":"E Akyar","year":"2018","unstructured":"Akyar E, Mora N, Luke A, Layden J, Phillips R, Agyarko-Poku T, et al. Risk Factors for Hepatitis C in Western Africa: An Observational Study in a STI Clinic. Open Forum Infect Dis. 2018;5(suppl1):S650\u2013650. https:\/\/doi.org\/10.1093\/ofid\/ofy210.1856.","journal-title":"Open Forum Infect Dis"},{"key":"13928_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/cid\/ciu965","volume":"60","author":"JE Layden","year":"2015","unstructured":"Layden JE, Phillips RO, Owusu-Ofori S, Sarfo FS, Kliethermes S, Mora N, et al. High Frequency of Active HCV Infection Among Seropositive Cases in West Africa and Evidence for Multiple Transmission Pathways. Clin Infect Dis. 2015;60:1033\u201341. https:\/\/doi.org\/10.1093\/cid\/ciu965.","journal-title":"Clin Infect Dis"},{"key":"13928_CR21","doi-asserted-by":"publisher","first-page":"103704","DOI":"10.1016\/j.bjid.2023.103704","volume":"27","author":"AE Quintas","year":"2023","unstructured":"Quintas AE, Dias CC, Cogle ADC, Cordeiro L, Sarmento A. Seroprevalence of viral transfusion transmissible infections (HBsAg, anti-HCV, anti-HIV, Syphilis) and coinfection among healthy volunteer blood donors during 5-years in Luanda, Angola. Brazilian J Infect Dis. 2023;27:103704. https:\/\/doi.org\/10.1016\/j.bjid.2023.103704.","journal-title":"Brazilian J Infect Dis"},{"key":"13928_CR22","unstructured":"Instituto Nacional de Estat\u00edstica. Inqu\u00e9rito de Indicadores M\u00faltiplos e de Sa\u00fade 2015\u20132016 (IIMS). INE-Angola. June 5, 2017;1\u2013559. https:\/\/www.ine.gov.ao\/publicacoes\/detalhes\/MjQyOTU%3D."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13928-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13928-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13928-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:02:56Z","timestamp":1790161376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13928-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13928"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13928-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study adhered to the ethical principles outlined in the Declaration of Helsinki and was approved by the General Management of the MEDIAG Clinic (approval number DTG-MED-05-007\/2025).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1701"}}